Medicare Enrolled

Dr. Romeo Majano, MD

Interventional Cardiology · South Miami, FL
Practice pattern: Cardiac & Remote— Practice combining cardiac and remote services
Low-engagement
7330 SW 62ND PL, South Miami, FL 33143
3056631001
In practice since 2006 (20 years)
NPI: 1225090921 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Majano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Majano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Majano

Dr. Romeo Majano is an interventional cardiology in South Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Majano performed 2,222 Medicare services across 1,258 unique beneficiaries.

Between the years covered by Open Payments, Dr. Majano received a total of $3,745 from 32 pharmaceutical and/or device companies across 140 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Majano is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 48% volume in FL$ $3,745 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,222
Medicare services
Top 48% in FL for interventional cardiology
1,258
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~111 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)289$65$195
Electrocardiogram (EKG), 12-lead285$11$33
Regadenoson injection (Lexiscan) for heart stress test230$42$110
Remote patient monitoring management, 20 min/month203$34$105
Office visit, established patient (30-39 min)171$94$270
Remote patient monitoring device, 30 days151$37$110
Technetium tc-99m tetrofosmin, diagnostic, per study dose142$337$500
EKG interpretation and report121$7$11
Echocardiogram, transthoracic108$148$424
Ultrasound of both sides of head and neck blood flow77$152$416
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician74$47$150
Nuclear medicine studies of heart muscle at rest and with stress and spect71$348$960
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes62$29$91
Blood draw (venipuncture)39$6$6
Ultrasonic guidance for blood vessel access29$13$32
Hospital follow-up visit, high complexity26$97$220
Cardiac catheterization24$243$720
New patient office visit (45-59 min)19$102$360
Initial hospital admission, high complexity18$148$430
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional15$19$57
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional15$683$1,860
Ultrasound of heart, follow-up14$20$43
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional13$50$160
Ultrasound of heart blood flow, valves and chambers, follow-up13$6$12
Ultrasound of heart with color-depicted blood flow, rate and valve function13$2$5
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.1% high complexity
21.0% medium
71.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,745
Total received (2018-2024)
Avg $535/year across 7 years
Bottom 27% in FL for interventional cardiology
32
Companies
140
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,745 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$643
2023
$673
2022
$1,094
2021
$377
2020
$292
2019
$302
2018
$364

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
CMS Imaging, Inc.
$746
Boston Scientific Corporation
$409
CARDIVA MEDICAL, INC.
$303
Janssen Pharmaceuticals, Inc
$289
Novo Nordisk Inc
$267
ASAHI INTECC USA, INC.
$227
PFIZER INC.
$215
E.R. Squibb & Sons, L.L.C.
$207
Amgen Inc.
$186
Novartis Pharmaceuticals Corporation
$82
Astellas Pharma US Inc
$75
Impulse Dynamics (USA) Inc.
$70
Medtronic, Inc.
$70
SANOFI-AVENTIS U.S. LLC
$66
Abbott Laboratories
$61
Amarin Pharma Inc.
$60
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$53
Kiniksa Pharmaceuticals International, plc
$51
Chiesi USA, Inc.
$46
ABIOMED
$32
Allergan Inc.
$28
Kiniksa Pharmaceuticals, Ltd.
$24
Esperion Therapeutics, Inc.
$23
AstraZeneca Pharmaceuticals LP
$21
Sanofi Pasteur Inc.
$20
ZOLL Circulation Inc
$19
BOSTON SCIENTIFIC CORPORATION
$19
ACIST MEDICAL SYSTEMS, INC.
$17
Aegerion Pharmaceuticals, Inc.
$16
BIOTRONIK INC.
$16
ARBOR PHARMACEUTICALS, INC.
$13
Biosense Webster, Inc.
$12
Top 3 companies account for 38.9% of total payments
Associated products mentioned in payments ›
ASAHI PTCA Guide Wire · Acunav · Arcalyst · BYSTOLIC · CARDIVA VASCADE MVP VVCS 6-12F · COBALT DR MRI SURESCAN · Cardiva VASCADE MVP VVCS 6-12F · ELIQUIS · ENTRESTO · Edarbyclor · FARXIGA · FLUZONE HIGH-DOSE · General - Vascular Access · Impella · JUXTAPID · KENGREAL · LEQVIO · LEXISCAN · LifeVest · MULTAQ · MitraClip System · NEXLETOL · Optimizer · Optimizer Smart System · Ozempic · PERIPHERAL VASCULAR · PRALUENT · Proclaim Family of SCS IPGs · RXI SYSTEMS · RYBELSUS · Repatha · Rybelsus · SAVVYWIRE · TherOx DS2 Console · VYNDAQEL · Vascepa · Vascular Closure Device · WATCHMAN Access System · WATCHMAN FLX · WOLVERINE · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $169 per 100 Medicare services performed
Looking for a interventional cardiology in South Miami?
Compare interventional cardiologys in the South Miami area by procedure volume, costs, and industry payment transparency.
Browse interventional cardiologys nearby

Geographic Context

Interventional Cardiologys within 10 mi
53
Per 100K population
2.0
County median income
$68,694
Nearest hospital
SOUTH MIAMI HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Majano is a cardiac & remote specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Majano experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Majano performed 289 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Majano receive payments from pharmaceutical companies?
Yes. Dr. Majano received a total of $3,745 from 32 companies across 140 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Majano's costs compare to other interventional cardiologys in South Miami?
Dr. Majano's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Majano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →